PubRank

John T Welch

Author PubWeight™ 15.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells. Antimicrob Agents Chemother 2009 1.13
2 Preparation and utility of organic pentafluorosulfanyl-containing compounds. Chem Rev 2014 1.00
3 Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli. Antimicrob Agents Chemother 2006 0.98
4 Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs. Antimicrob Agents Chemother 2007 0.90
5 Genetic engineering combined with deep UV resonance Raman spectroscopy for structural characterization of amyloid-like fibrils. J Am Chem Soc 2008 0.86
6 Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy. Antimicrob Agents Chemother 2010 0.85
7 Design and preparation of beta-sheet forming repetitive and block-copolymerized polypeptides. Biomacromolecules 2007 0.84
8 Bilayer fibril formation by genetically engineered polypeptides: preparation and characterization. Biomacromolecules 2006 0.83
9 Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic. Bioorg Med Chem 2003 0.81
10 Charge distribution and amyloid fibril formation: insights from genetically engineered model systems. Biomacromolecules 2010 0.80
11 A de novo designed 11 kDa polypeptide: model for amyloidogenic intrinsically disordered proteins. Biopolymers 2010 0.80
12 Reversible thermal denaturation of a 60-kDa genetically engineered beta-sheet polypeptide. Biophys J 2006 0.79
13 Fibrillation mechanism of a model intrinsically disordered protein revealed by 2D correlation deep UV resonance Raman spectroscopy. Biomacromolecules 2012 0.79
14 Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis. Indian J Med Res 2012 0.79
15 Sirtuin 6: a review of biological effects and potential therapeutic properties. Mol Biosyst 2013 0.79
16 Designer variable repeat length polypeptides as scaffolds for surface immobilization of quantum dots. J Phys Chem B 2006 0.78
17 Beta-sheet folding of 11-kDa fibrillogenic polypeptide is completely aggregation driven. Biopolymers 2007 0.76
18 Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I. Bioorg Med Chem Lett 2011 0.76
19 Synthesis of mono- and difluoroacetyltrialkylsilanes and the corresponding enol silyl ethers. J Org Chem 2004 0.75
20 The role of proline-containing peptide triads in β-sheet formation: A kinetic study. Biopolymers 2015 0.75
21 Chimera-induced folding: implications for amyloidosis. Biomacromolecules 2014 0.75
22 Analogs of the antituberculous agent pyrazinamide are competitive inhibitors of NADPH binding to M. tuberculosis fatty acid synthase I. Chem Biodivers 2012 0.75
23 Metallization of a genetically engineered polypeptide. Macromol Biosci 2011 0.75
24 The catalytic Mannich reaction of 1,1-difluoro-2-trialkyl(aryl)silyl-2-trimethyl-silyloxyethenes: preparation of beta-amino acid derivatives. J Org Chem 2005 0.75
25 Preparation and characterization of alkenyl aryl tetrafluoro-λ(6) -sulfanes. Angew Chem Int Ed Engl 2013 0.75